Your skin and your gut are not separate systems. They share embryological origin (both develop from the ectodermal and endodermal germ layers), communicate via hormonal and immune signaling, and share microbial relationships — the skin has its own microbiome that responds to changes in the gut microbiome. The "gut-skin axis" describes the bidirectional communication network between these two organ systems, mediated primarily by the immune system, the HPA axis (stress hormones), and short-chain fatty acids from gut fermentation.
Pathway 1: Intestinal permeability → LPS → systemic inflammation: When tight junctions break down (from dysbiosis, alcohol, NSAIDs, ultra-processed food), lipopolysaccharide (LPS) from gram-negative bacteria enters the bloodstream. LPS triggers Toll-like receptor 4 (TLR4) on immune cells throughout the body — including in skin — driving IL-1β, IL-6, and TNF-α production. This is the same inflammatory pathway that drives acne lesions, rosacea flushing, eczema flares, and psoriasis plaques.
Pathway 2: SCFA production → skin barrier integrity: Butyrate and other SCFAs from fiber fermentation reduce systemic inflammation and support skin barrier function through multiple mechanisms including epigenetic regulation of inflammatory gene expression. People with lower dietary fiber intake have lower SCFA production and measurably more permeable skin barriers.
Pathway 3: Cortisol and the HPA axis: Stress activates the HPA axis, elevating cortisol — which both increases intestinal permeability (stress directly loosens tight junctions) and upregulates sebum production in sebaceous glands. This is the mechanism behind stress-induced acne breakouts: cortisol → more sebum + more gut permeability + more systemic inflammation.
The gut-acne link operates through two primary mechanisms: IGF-1 signaling and inflammatory load. High glycemic index diets spike blood glucose → insulin → IGF-1 (insulin-like growth factor 1) → upregulated sebum production and androgen signaling in sebaceous follicles. Dairy (particularly milk) independently raises IGF-1 regardless of glycemic index — a well-replicated finding across multiple prospective cohort studies.
The microbiome angle: gut dysbiosis reduces microbial production of short-chain fatty acids that normally suppress sebum-stimulating pathways. People with acne have been shown to have lower gut microbiome diversity and altered Firmicutes/Bacteroidetes ratios compared to clear-skin controls in some studies (though this remains correlation-level evidence).
Dietary interventions with evidence: Low glycemic index diet (consistent RCT data for acne reduction); reducing dairy, particularly skim milk (multiple prospective cohort studies). These aren't alternative medicine — they're in multiple dermatology society guidelines as adjuncts to topical treatment.
The rosacea-SIBO connection is the most clinically compelling in the gut-skin axis literature. A 2008 RCT found that 46% of rosacea patients had SIBO (vs. controls). More importantly: treating SIBO with rifaximin resolved rosacea lesions in 96% of SIBO-positive patients and reduced recurrence at 9 months — dramatically outperforming the standard topical rosacea treatments in that cohort.
The proposed mechanism: bacterial overgrowth in the small intestine increases LPS systemic load and substance P (a neuropeptide that triggers vasodilation and flushing). Helicobacter pylori gastric infection is also associated with rosacea in multiple studies; H. pylori eradication improves rosacea.
If you have rosacea that doesn't respond well to topical metronidazole or azelaic acid, SIBO testing via breath test is a clinically reasonable next step. See our SIBO guide for testing and treatment protocols.
The gut-eczema connection is most pronounced in early life. Multiple prospective cohort studies show that low gut microbiome diversity in infants at 1–3 months of age predicts higher rates of atopic dermatitis by age 2. Cesarean section delivery (which bypasses the vaginal microbiome seeding of the birth canal), antibiotic use in infancy, and formula feeding (vs. breastfeeding) are all associated with increased eczema risk — likely mediated by their effects on early gut microbiome colonization.
In adults, eczema flares correlate with gut dysbiosis and intestinal permeability — the same LPS → TLR4 → IL-4/IL-13 pathway that drives the Th2-biased immune response in atopy.
Probiotic evidence: L. rhamnosus GG (Culturelle) supplementation in pregnancy and early infancy has the strongest RCT evidence for reducing eczema risk in high-risk infants — multiple trials, though the effect size is modest.
30+ plant foods/week increases SCFA production and reduces systemic LPS load. Most direct impact on skin inflammation baseline.
Kimchi, kefir, yogurt increase microbiome diversity and reduce inflammatory cytokines (Cell 2022 RCT).
Reduces IGF-1 signaling; consistent RCT evidence for acne lesion reduction. Most directly evidence-backed dietary acne intervention.
Strongest probiotic evidence for atopic dermatitis, particularly for risk reduction in infants of atopic parents.
Multi-strain Bifidobacterium + Lactobacillus; gut barrier support that may reduce systemic inflammatory burden secondarily improving skin.
If rosacea is refractory to standard topical treatment, breath test for SIBO is clinically indicated per the RCT evidence above.